Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...

A Life Sciences Project Accelerator Kicks into High Gear

XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTC: XPHYF) has been a hot story lately, especially in Germany, due to its recent commercialization of a super-fast PCR test kit for definitively diagnosing COVID-19 infections in point-of-care settings. The company rec...

How This Company is Tapping Into the Growing Cannabis Vaping Market

(Click image to watch video) Cannabis vape products, in particular, have been gaining traction as legalization of the recreational drug becomes more widespread in certain U.S. states. Case in point, it is estimated that in states like California, Colorado, Ne...

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...

The Great White North of Debt: What Canada's Monetary Policies Mean

As I sit here on a Thursday evening, contemplating the logic behind my most recent additions to a highly tentative short position on the SPY:US (the exchange-traded fund [ETF] tracking the S&P 500), I am doing everything in my power to not take my quote machine and proj...

Mackie Research: Small Cap a World Leader in Health and Safety Wearables

Note: This article is not research and any companies mentioned are not rated. TraceSafe Technologies Inc . is a wholly owned subsidiary of Blockchain Holdings Ltd. (BCX:CSE) , and owns 100% of the rights and interests in the real-time location tracking technology ...

Living in a virus-controlled world

As the coronavirus pandemic continues to infect populations, though in some countries it is slowing, talk has shifted to re-opening economies, and to manufacturing a vaccine that drug companies hope will not only work, but can be distributed at large enough doses to provide ...

Five Small Caps Expanding Their Business Amid the Covid-19 Pandemic

Some small caps are finding new opportunities during the Covid-19 pandemic. While the extreme market volatility over the past weeks creates a lot of uncertainly, some companies have seen business increase amid the Covid-19 epidemic. Here are a handful of sma...
1 2